PassionBio accelerates drug development and transforms pharma assets through an active investment approach. The company is built around leading former BioNTech executives with backgrounds from major pharma organizations including Sanofi, GSK, Johnson & Johnson, and Takeda, and is strengthened by resources from financing and fund management. We target programs where we can shape or redesign the clinical plan to achieve faster timelines, clinically meaningful benefit, and real-world health impact over the standard-of-care at the time of launch. We engage hands-on through operational work and repositioning, including equity-based partnerships that draw on our expertise and global network. Together with co-financing partners, we lay the groundwork for PassionBio Capital to drive buyout, licensing, and exit opportunities.